Sugi Predict

Sugi Predict / Compounds / SCHEMBL7189068

SCHEMBL7189068

SCHEMBL7189068

Cc1cccc(Cl)c1C(=O)Pc1c(OCC(C)C)cc(OCC(C)C)cc1OCC(C)C.[LiH]

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PTGER1 P34995 6/20 0.38
▸ FOS P01100 2/20 0.37
▸ JUN P05412 2/20 0.37
▸ TRPM4 Q8TD43 1/20 0.36
▸ FFAR1 O14842 1/20 0.35
▸ NFKB1 P19838 1/20 0.34
▸ NFKB2 Q00653 1/20 0.34
▸ RELA Q04206 1/20 0.34
▸ XDH P47989 1/20 0.34
▸ TBXA2R P21731 1/20 0.34
▸ PPARG P37231 1/20 0.34
▸ PTGER3 P43115 1/20 0.34
▸ KMT2A Q03164 2/20 0.34
▸ ALDH1A1 P00352 1/20 0.34
▸ MAPT P10636 1/20 0.34
▸ HTR1D P28221 2/20 0.33
▸ MEN1 O00255 1/20 0.33
▸ KEAP1 Q14145 1/20 0.33
▸ NFE2L2 Q16236 1/20 0.33
▸ ABL1 P00519 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7181868 0.94 FOS (0.40) PTGER1FOSJUNNFKB1NFKB2
SCHEMBL7179778 0.92 FOS (0.40) PTGER1FOSJUNFFAR1NFKB1
SCHEMBL7175199 0.89 FOS (0.37) PTGER1FOSJUNMAPTHTR1D
SCHEMBL7187585 0.87 S1PR1 (0.37) TRPM4MAPT
SCHEMBL7181505 0.87 FOS (0.38) PTGER1FOSJUNTRPM4FFAR1
SCHEMBL7181471 0.85 ELANE (0.43) TRPM4ALDH1A1MAPTABL1SRC
Lithium SCHEMBL7181512 0.85 FOS (0.36) PTGER1FOSJUNTRPM4FFAR1
SCHEMBL7186795 0.84 ALDH1A1 (0.41) TRPM4NFKB1NFKB2RELAPPARG
SCHEMBL7186458 0.83 ELANE (0.39) TRPM4FFAR1PPARGKMT2AALDH1A1
SCHEMBL7187939 0.83 NR1H4 (0.37) TRPM4FFAR1KMT2AALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6579663-B2 Chemical intermediates such as lithium 2,6-dimethylbenzoyl phenylphosphine for preparation of acylphosphines, acylphosphine oxides or acylphosphine sulfides CIBA SPECIALTY CHEMICALS CORPORATION 2003-06-17 — — US disclosed
US-20020107413-A1 Organometallic monoacylarylphosphines WOLF JEAN-PIERRE (CH) 2002-08-08 — — US disclosed
US-6399805-B2 SUCH AS LITHIUM 2,6-DIMETHYLBENZOYLPHENYLPHOSPHINE, USE AS PHOTOINITIATORS IN PHOTOCURABLE COMPOSITIONS SUCH AS FOR PHOTOGRAPHIC PRODUCTION OF RELIEF IMAGES CIBA SPECIALTY CHEMICALS CORPORATION 2002-06-04 — — US disclosed
US-20010031898-A1 Organometallic monoacylarylphosphines CIBA SPECIALTY CHEMICALS CORP. 2001-10-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020107413-A1 Organometallic monoacylarylphosphines CBR1, NAF1, DHCR24 PTGER1 3015/4885FOS 2702/4885JUN 4136/4885
US-20010031898-A1 Organometallic monoacylarylphosphines NAF1, DHCR24, CBR1 PTGER1 3796/4885FOS 2549/4885JUN 3781/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.